VITR Share Price Performance
SEK 136.50
-83.70 (-38.01%)
32.6% undervalued intrinsic discount
SEK 202.50
Fair Value
Price SEK 136.50
AnalystConsensusTarget SEK 202.50
Fair ValueSEK 202.50
Share PriceSEK 136.50
32.6% undervalued intrinsic discount
VITR Community Narratives
AN
Fair Value SEK 202.50 32.6% undervalued intrinsic discount
US IVF Treatment Rebound And APAC Reimbursements Will Drive Recovery
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Recent VITR News & Updates
No updates
Vitrolife AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 23, 2025
- Earnings per share (EPS)
- 3.36
- Gross Margin
- 58.85%
- Net Profit Margin
- 12.85%
- Debt/Equity Ratio
- 14.1%
Vitrolife AB (publ) Competitors
About VITR
- Founded
- 1989
- Employees
- 1147
- CEO
- WebsiteView website
Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
Swedish Market Performance
- 7 Days: -1.5%
- 3 Months: 2.8%
- 1 Year: 1.4%
- Year to Date: -0.4%
Over the last 7 days, the market has dropped 1.5%, driven by a decline of 2.3% in the Industrials sector. Although the market performance has been flat over the past year. Earnings are forecast to grow by 17% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading